About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Recherche
›
Press releases
About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Press releases
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
9
Jul 2015
20:30 E.S.T.
Cellectis Reaches Milestone in Servier Collaboration
Read more
11
Jun 2015
20:30 E.S.T.
Cellectis Announces Promising Study on Next Generation Engineered Allogeneic CAR T-cells
Read more
10
Jun 2015
20:30 E.S.T.
Cellectis Reports First Quarter 2015 Financial Results
Read more
5
Jun 2015
20:30 E.S.T.
Cellectis to Present Data on its Allogeneic CAR T-Cell Immunotherapy Programs at the European Hematology Association Annual Meeting
Read more
3
Jun 2015
20:30 E.S.T.
Weill Cornell Medical College and Cellectis Announce Research Alliance Advancing Drug Discovery and the Translation of Novel Immunotherapies in Leukemia
Read more
20
May 2015
20:30 E.S.T.
Cellectis SA Combined General Shareholders’ Meeting of May 18, 2015
Read more
14
May 2015
20:30 E.S.T.
Cellectis to Present Data on Genome Engineering for Adoptive Immunotherapy at the American Society of Clinical Oncology Annual Meeting
Read more
8
May 2015
20:30 E.S.T.
Cellectis S.A. to Present Data on its Allogeneic CAR T Cell Programs at American Society of Gene & Cell Therapy Annual Meeting
Read more
5
May 2015
20:30 E.S.T.
Cellectis Plant Sciences Becomes Calyxt
Read more
5
May 2015
20:30 E.S.T.
Cellectis S.A. Announces Calyxt is New Name for its Plant Sciences Subsidiary
Read more
Posts pagination
← PREV
1
2
3
NEXT →
Press contacts
For more information on any story, or for press enquiries, get in touch with our communication team
CONTACT US